This is the authors' abstract. We don't add key points for this paper.
Reuterin, a multifunctional bioactive compound synthesized by Limosilactobacillus reuteri during glycerol metabolism, exhibits predominantly antimicrobial activity. Co-culturing has been shown to be an effective strategy for regulating metabolic activities and production of specific metabolites. In this study, co-culturing Limosilactobacillus reuteri strain LR21 with Gram-positive and Gram-negative bacteria both significantly increased reuterin synthesis, even when exogenous bacteria were heat-killed. The further metabolomic analysis identified cholestenone as a key metabolite derived from lysed pathogens that boosts reuterin biosynthesis. RNA-seq and qPCR analyses further demonstrated that cholestenone treatment upregulates the expression of genes involved in reuterin biosynthesis ( gdht, pduA, pduB, pduC, pduD, pduE ) and genes involved in glycolysis, fatty acid biosynthesis, and amino acid biosynthesis, suggesting enhanced cellular metabolic activity that supports the synthesis of reuterin. Additionally, cholestenone significantly enhanced the antimicrobial effects of LR21 against pathogens during fermented meat production. These findings underscore the adaptive strategy of Limosilactobacillus reuteri in utilizing resources from competitors to enhance survival, offering valuable insights into microbial interactions and practical guidance for optimizing reuterin production in food and biotechnology applications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: